Private Equity Hub -- Paylon Medical Corp., a New York-based developer of implantable drug delivery systems, has raised $21 million in Series A funding. Baird Venture Partners led the round, and was joined by Hambrecht & Quist Capital Management, Fountain Healthcare Partners, BB Biotech Ventures, Cross Atlantic Partners and Arcus Ventures.